PATENT CLAIM ANALYSIS

Application Number: 15942521
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-10
Patent Classification: ["424", "204100"]

Abstract:
The present invention Provides composition and method for stimulating immune responses against antigens without using conventional adjuvants (such as aluminum salt adjuvants, oil-in-water emulsion adjuvants, toll-like receptor agonist adjuvants, and the like). The composition contains p14.7 protein and an antigen to which the stimulated illumine responses are desired. The p14.7 protein functions as an adjuvant so that the immune responses to the antigen stimulated by the composition comprising p14.7 protein and the antigen are greater than the immune responses stimulated by the antigen alone. The current invention also provides a method for producing thermostable vaccines and a simple strategy for avoiding vaccine cold-chain maintenance by lyophilization.

Claim (Index 1):
An immunogenic composition comprising a p14.7 adjuvant protein and a heterologous antigen, wherein said p14.7 adjuvant protein and said heterologous antigen are directly or indirectly linked together.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.74242
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13872503', '10837117', '12791020', '12708095', '11153222']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7353908599108974
- 35 USC 102 Novelty (BERT): 0.5148948927172327
- Combined Prediction Score: 0.7133412631915309
- Mean Citation Score: 277.6189820000001
- Max Citation Score: 290.5116
- Similarity Product: 187.9909485829353

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test